Unknown Billionaire Phill Gross’ Top 10 Stock Picks
In the article, we discussed unknown billionaire Phil Gross’ top 10 stock picks and portfolio management strategy. Click to skip our discussion...
Posts Tagged ‘NASDAQ:ALXN’
Billionaire Paul Tudor Jones’ Top 10 Stock Picks and Latest Portfolio
In this article we presented billionaire Paul Tudor Jones’ top 10 stock picks. You can skip our detailed analysis of Jones’ investment strategy...
Is Alexion (ALXN) Stock A Buy Or Sell?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on...
Alexion Pharmaceuticals (ALXN) Bullish Thesis
We came across a bullish Alexion Pharmaceuticals (ALXN) thesis on Valueinvestorsclub posted by skca74. Valueinvestorsclub is one of our favorite sites...
Is ALXN A Good Stock To Buy Now?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors...
Lookback: Miller Value Partners 2019 Alexion Pharmaceuticals (ALXN) Thesis
If you are looking for the best ideas for your portfolio you may want to consider some of Miller Value Partners top stock picks. Miller Value Partners...
Were Hedge Funds Right About Piling Into Alexion Pharmaceuticals, Inc. (ALXN)?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact,...
Hedge Funds Keep Buying Alexion Pharmaceuticals, Inc. (ALXN)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish...
Were Hedge Funds Right About Piling Into Alexion Pharmaceuticals, Inc. (ALXN)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish...
Should You Be Tempted To ‘Sell’ Alexion Pharmaceuticals (ALXN) Stock
Miller Value Partners recently released its Q1 2020 Investor Letter, a copy of which you can download here. The Miller Value Partners Opportunity Equity...
Hedge Funds Have Never Been This Bullish On Alexion Pharmaceuticals, Inc. (ALXN)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
Hedge Fund and Insider Trading News: Anthony Scaramucci, Boaz Weinstein, George Soros, Cheyne Capital, Elliott Management, Rent-A-Center Inc (RCII), Evans Bancorp Inc. (EVBN), and More
Hedge Fund Cheyne Raising Cash for Debt Oversold in Pandemic (Bloomberg) London-based hedge fund Cheyne Capital is planning a new vehicle to buy up debt...
Were Hedge Funds Right About Alexion Pharmaceuticals (ALXN)?
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we published an article with the title Recession...
Is Alexion Pharmaceuticals, Inc. (ALXN) A Good Stock To Buy?
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we published this article and predicted that a...
How Did Alexion Pharmaceuticals, Inc. (ALXN) Compare Against Top Hedge Fund Stocks in 2019?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge...
Hedge Fund and Insider Trading News: Bill Ackman, Steve Cohen, MSD Capital, Magnetar Capital, Elliott Management, salesforce.com, inc. (CRM), American States Water Co (AWR), and More
Michael Dell’s Money Managers Change How His Wealth Is Invested (The Wall Street Journal) Michael Dell’s money managers are making the most significant...
Hedge Funds Are Getting Crazy About Alexion Pharmaceuticals, Inc. (ALXN)
Is Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive...
Miller Value Partners Likes These Two Stocks; Bearish on One
Miller Value Partners recently released its 2019 Q3 investor letter – you can download a copy here. The investment management firm did not have a...
Here is What Hedge Funds Think About Alexion Pharmaceuticals, Inc. (ALXN)
Hedge funds and other investment firms run by legendary investors like Israel Englander, Jeffrey Talpins and Ray Dalio are entrusted to manage billions...
Here’s What Hedge Funds Think About Alexion Pharmaceuticals, Inc. (ALXN)
Hedge funds are not perfect. They have their bad picks just like everyone else. Facebook, a stock hedge funds have loved dearly, lost nearly 40% of its...
Alexion Pharmaceuticals, Inc. (ALXN): Sound Shore Says the Pharmaceutical Company is Driving Innovation
Sound Shore posted 20 year annualized returns of 7.30% and 7.51% for its Sound Shore Fund Investor Class (SSHFX) and Institutional Class (SSHVX), respectively...
Is Alexion Pharmaceuticals, Inc. (ALXN) A Good Stock To Buy Right Now?
Is Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) an attractive stock to buy now? Money managers are betting on the stock. The number of bullish hedge fund...
Should You Avoid Alexion Pharmaceuticals, Inc. (ALXN)?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They...
Market Movers Today: CSRA Inc (CSRA), Ulta Beauty Inc (ULTA), Stamps.com (STMP), and More
CSRA Inc (NYSE:CSRA) (Bloomberg) General Dynamics Corp., the maker of Abrams tanks and nuclear submarines, is making a record bet on reinvigorating its...
11 Best Growth Company Stocks To Buy Now
The 11 best growth company stocks to buy now are often characterized by strong sales growth, solid management team, attractive valuations, and a growing...
Check Out These 34 Stories To Find Out What’s Happening In The Financial Markets Today
1. U.S. Stock Market: “U.S. equities traded higher on Wednesday as investors cheered the Federal Reserve’s plan for scaling back its massive...
32 Key News Stories from the World of Finance Today
1. U.S. Stock Market: “The S&P 500 traded higher on Tuesday and nearly erased the losses suffered from the biggest sell-off of the year...
Alexion Pharmaceuticals, Inc. (ALXN) Suffers Another Blow In The UK
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has had another misfortune in the UK. The country’s public health watchdog, NICE (the National Institute...
Is Alexion Pharmaceuticals, Inc. (ALXN) a Good Stock To Buy?
The SEC requires hedge funds and wealthy investors with over a certain portfolio size to file a report that shows their positions at the end of every...
Incyte Corporation (INCY), Seattle Genetics, Inc. (SGEN) & Two More: Top Healthcare Hedge Fund Loves These Stocks
Baker Bros. Advisors is a fund managed by Julian Baker and Felix Baker that mainly invests in biotechnology companies, and today we are going to take...
10 Most Successful Innovative Companies in The World in 2016
Which are the most successful innovative companies in the world in 2016? Bringing something new to the table is something that seems to be difficult these...
Today’s Trending Stocks: Pioneer, Ariad, Hershey, and 2 More
Crude futures are in the red today as sentiment around the commodity cools off. Meanwhile the Dow, Nasdaq, and S&P 500 are relatively flat as traders...
Stocks Not Having A Good Day: Catalent, Alexion Pharmaceuticals, DryShips, More
U.S stocks have edged higher on Tuesday following a rise in oil prices and Fed Chairwoman Janet Yellen’s speech on Monday, in which she maintained an...
Stumbling Biotech Stocks Spell Doom for Baker Bros. Advisors
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused...
Healthcare-focused Baker Bros. Advisors’ Top Picks: Incyte, Alexion, ACADIA & More
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies...
Hedge Funds Are Selling These 10 Large-Caps, Part 1
Professional money managers are quick to judge when things start to turn sour for a particular company. Generally, it would do retail investors well ...
Top 5 Healthcare Bets of World-Class Baker Bros. Advisors
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker...
Is Alexion Pharmaceuticals, Inc. (ALXN) A Good Stock To Buy?
Concerns over a shift in Fed’s easy monetary policy have hit several hedge funds hard during the third quarter. A number of sectors are in correction...
Mariner Investment Group’s Top Biotech Stock Picks For Q4
Mariner Investment Group is a New York-based investment advisory firm founded by William Michaelcheck in 1992. Apart from its headquarters in New York...
Don’t Miss White-Hot Baker Bros.’ New Healthcare Picks
At Insider Monkey, we track over 700 hedge funds and investment companies, which allows us to understand the market sentiment towards any given stock....
Synageva Biopharma Corp (GEVA) Acquisition Helps Baker Bros. Advisors Top All Others In Q2 Returns
With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker‘s Baker Bros. Advisors is making a habit of hitting...
What The Smart Money Thinks Of Barclays’ Top Healthcare Picks: Alexion Pharmaceuticals, Inc. (ALXN), Baxter International Inc (BAX), & Valeant Pharmaceuticals Intl Inc (VRX)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Baxter International Inc (NYSE:BAX), and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) are among the top healthcare...
James Dinan is Betting on Broadcast TV, Obamacare & JPMorgan
We have compared billionaire James Dinan’s York Capital Management’s most recent 13F to the fund’s previous filings (see a history of Dinan’...
The ‘Smart Money’ Loves The 500% Upside On This Biopharma Stock
Orphan drugs, those treating rare conditions for small segments of the population, do not normally get much attention compared with the likes of a $12...
Alexion Pharmaceuticals, Inc. (ALXN), Pharmacyclics, Inc. (PCYC), Aegerion Pharmaceuticals, Inc. (AEGR), Raptor Pharmaceutical Corp. (RPTP): Have These Four Biotechs Peaked?
Biotechnology stocks often trade with excessive valuations, until one day, large losses occur. The best way to protect yourself is to be logical when...
NPS Pharmaceuticals, Inc. (NPSP), Eli Lilly & Co. (LLY), Alexion Pharmaceuticals, Inc. (ALXN): Three Justifications for the High Cost of Gattex
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) has priced its Gattex drug for short bowel syndrome, or SBS, at $295,000, expecting to make peak sales of $350...
Alexion Pharmaceuticals, Inc. (ALXN), Amgen, Inc. (AMGN), Baxter International Inc. (BAX): The Treatment of Rare Diseases Offers Unique Opportunities
A company with a modus operandi of tackling rare and very rare diseases might not necessarily jump out as a great investment, but this company has...
Should You Buy Regeneron Pharmaceuticals Inc (REGN)?
Is Regeneron Pharmaceuticals Inc (NASDAQ:REGN) a good investment? If you were to ask many investors, hedge funds are viewed as delayed, outdated investment...
What Hedge Funds Think About Vertex Pharmaceuticals Incorporated (VRTX)
Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) a buy? In the 21st century investor’s toolkit, there are tons of metrics market participants can...
Do Hedge Funds and Insiders Love Alexion Pharmaceuticals, Inc. (ALXN)?
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) investors are standing pat. In the 21st century investor’s toolkit, there are dozens of indicators investors...
